Treatment of hepatic carcinoma by low-frequency ultrasound and microbubbles: A case report

Shen,Zhi‑Yong; Wu,Ming‑Feng; Zhang,Yi‑Xin; Shen,Kang; Xia,Gan‑Lin

doi:10.3892/ol.2014.2812

Treatment of hepatic carcinoma by low-frequency ultrasound and microbubbles: A case report

Authors:
- Zhi‑Yong Shen
- Ming‑Feng Wu
- Yi‑Xin Zhang
- Kang Shen
- Gan‑Lin Xia
View Affiliations

Affiliations: Department of Radiology, Nantong University Affiliated Nantong Tumor Hospital, Nantong, Jiangsu 226361, P.R. China
Published online on: December 18, 2014 https://doi.org/10.3892/ol.2014.2812
Pages: 1249-1253

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In vitro and in vivo studies have identified that low‑frequency ultrasound (US) and microbubbles (MBs) mediate tumor inhibitory effects. However, the application of US in the clinical setting remains unclear. The aim of the present study was to investigate the clinically therapeutic effect of 20 kHz US in combination with MBs for the treatment of hepatic carcinoma. A 71‑year‑old male with a hepatic malignant tumor was admitted to Nantong University Affiliated Nantong Tumor Hospital (Nantong, China). The patient was subsequently sonicated with 20 kHz US and MBs over a period of five days. The low‑frequency US parameters were set at 20 kHz, 2 W/cm2, duty cycle 40% (on 2 sec, off 3 sec) for a duration of 5 min each day for a total of five days. Computed tomography (CT), contrast‑enhanced US (CEUS) and carbohydrate antigen 19‑9 (CA19‑9) tests were performed to evaluate the therapeutic effects. Although the tumor size increased marginally on CT from 5.4 to 5.6 cm after US treatment, the intensity and enhanced‑areas on the CT scans and CEUS decreased. The abdominal lymph node decreased in size, from 2.2 to 1.9 cm, and CA19‑9 levels decreased from the pretreatment value of 2,007 to 734 U/ml. Therapy with low‑frequency US combined with MBs may exhibit an antivasculature effect and may be used as a palliative treatment for patients with unresectable hepatic malignant tumors.

View Figures

View References

1	Jung SE, Cho SH, Jang JH and Han JY: High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: complications. Abdom Imaging. 36:185–195. 2011. View Article : Google Scholar
2	Tonucci LB, Mourão DM, Ribeiro AQ and Bressan J: Noninvasive body contouring: biological and aesthetic effects of low-frequency, low-intensity ultrasound device. Aesthetic Plast Surg. 38:959–967. 2014. View Article : Google Scholar : PubMed/NCBI
3	Baron C, Aubry JF, Tanter M, Meairs S and Fink M: Simulation of intracranial acoustic fields in clinical trials of sonothrombolysis. Ultrasound Med Biol. 35:1148–1158. 2009. View Article : Google Scholar : PubMed/NCBI
4	Rubiera M and Alexandrov AV: Sonothrombolysis in the management of acute ischemic stroke. Am J Cardiovasc Drugs. 10:5–10. 2010. View Article : Google Scholar : PubMed/NCBI
5	Son Y, Lim M, Khim J and Ashokkumar M: Acoustic emission spectra and sonochemical activity in a 36 kHz sonoreactor. Ultrason Sonochem. 19:16–21. 2012. View Article : Google Scholar
6	Schlicher RK, Hutcheson JD, Radhakrishna H, Apkarian RP and Prausnitz MR: Changes in cell morphology due to plasma membrane wounding by acoustic cavitation. Ultrasound Med Biol. 36:677–692. 2010. View Article : Google Scholar : PubMed/NCBI
7	Miller DL and Dou C: The influence of octyl β-D-glucopyranoside on cell lysis induced by ultrasonic cavitation. J Acoust Soc Am. 130:3482–3848. 2011. View Article : Google Scholar : PubMed/NCBI
8	Hutcheson JD, Schlicher RK, Hicks HK and Prausnitz MR: Saving cells from ultrasound-induced apoptosis: quantification of cell death and uptake following sonication and effects of targeted calcium chelation. Ultrasound Med Biol. 36:1008–1021. 2010. View Article : Google Scholar : PubMed/NCBI
9	Skyba DM, Price RJ, Linka AZ, Skalak TC and Kaul S: Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation. 98:290–293. 1998. View Article : Google Scholar : PubMed/NCBI
10	Frenkel V: Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev. 60:1193–1208. 2008. View Article : Google Scholar : PubMed/NCBI
11	Wood AK, Ansaloni S, Ziemer LS, et al: The antivascular action of physiotherapy ultrasound on murine tumors. Ultrasound Med Biol. 31:1403–1410. 2005. View Article : Google Scholar : PubMed/NCBI
12	Bunte RM, Ansaloni S, Sehgal CM, Lee WM-F and Wood AK: Histopathological observations of the antivascular effects of physiotherapy ultrasound on a murine neoplasm. Ultrasound Med Biol. 32:453–461. 2006. View Article : Google Scholar : PubMed/NCBI
13	Wood AK, Schultz SM, Lee WM, Bunte RM and Sehgal CM: Antivascular ultrasound therapy extends survival of mice with implanted melanomas. Ultrasound Med Biol. 36:853–857. 2010. View Article : Google Scholar : PubMed/NCBI
14	Shen ZY, Shen E, Zhang JZ, et al: Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice. Oncol Rep. 30:842–850. 2013.PubMed/NCBI
15	Shen ZY, Shen E, Diao XH, et al: Inhibitory effects of subcutaneous tumors in nude mice mediated by low-frequency ultrasound and microbubbles. Oncol Lett. 7:1385–1390. 2014.PubMed/NCBI
16	Herber S, Otto G, Schneider J, et al: Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol. 30:1156–1165. 2007. View Article : Google Scholar : PubMed/NCBI
17	Marcus C, Ladam-Marcus V, Cucu C, et al: Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol. 72:217–238. 2009. View Article : Google Scholar
18	Spina JC, Ulla M, Yeyati EL, et al: MDCT findings after hepatic chemoembolization with DC-beads: what the radiologist needs to know. Abdom Imaging. 38:778–784. 2013. View Article : Google Scholar
19	Dierckx R, Maes A, Peeters M and Van De Wiele C: FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases. Q J Nucl Med Mol Imaging. 53:336–342. 2009.PubMed/NCBI
20	Qin S, Caskey CF and Ferrara KW: Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol. 54:R27–R57. 2009. View Article : Google Scholar : PubMed/NCBI
21	Chen H, Kreider W, Brayman AA, Bailey MR and Matula TJ: Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett. 106:0343012011. View Article : Google Scholar : PubMed/NCBI
22	Miller DL, Averkiou MA, Brayman AA, et al: Bioeffects considerations for diagnostic ultrasound contrast agents. J Ultrasound Med. 27:611–632. 2008.PubMed/NCBI
23	Chen H, Kreider W, Brayman AA, Bailey MR and Matula TJ: Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett. 106:0343012011. View Article : Google Scholar : PubMed/NCBI
24	Chen H, Brayman AA, Bailey MR and Matula TJ: Blood vessel rupture by cavitation. Urol Res. 38:321–326. 2010. View Article : Google Scholar : PubMed/NCBI
25	Holland CK and Apfel RE: An improved theory for the prediction of microcavitation thresholds. IEEE Trans Ultrason Ferroelectr Freq Control. 36:204–208. 1989. View Article : Google Scholar : PubMed/NCBI
26	Basta G, Venneri L, Lazzerini G, et al: In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound. Cardiovasc Res. 58:156–161. 2003. View Article : Google Scholar : PubMed/NCBI
27	Shen ZY, Xia GL, Wu MF, et al: The effects of low-frequency ultrasound and microbubbles on rabbit hepatic tumors. Exp Biol Med (Maywood). 239:747–757. 2014. View Article : Google Scholar
28	Zitvogel L and Kroemer G: Anticancer effects of imatinib via immunostimulation. Nat Med. 17:1050–1051. 2011. View Article : Google Scholar : PubMed/NCBI
29	Liu ZH, Chen Z, Ma LL, Li XH and Wang LX: Factors influencing the prognosis of patients with intrahepatic cholangiocarcinoma. Acta Gastroenterol Belg. 75:215–218. 2012.PubMed/NCBI
30	Tangkijvanich P, Thong-ngam D, Theamboonlers A, et al: Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma. Hepatogastroenterology. 51:15–19. 2004.PubMed/NCBI
31	Yoshida K, Hirokawa T, Moriyasu F, et al: Arterial-phase contrast-enhanced ultrasonography for evaluating anti-angiogenesis treatment: a pilot study. World J Gastroenterol. 17:1045–1050. 2011. View Article : Google Scholar : PubMed/NCBI